|
|
 |
|
Viewing report
|
|
|
|
Cystic Fibrosis - Global Strategic Business Report
Global Industry Analysts, Inc., June 2010, Pages: 402
This report analyzes the US market for Cystic Fibrosis in Millions of US$. Annual estimates and forecasts are provided for the period of 2007 through 2015. Also, a six-year historic analysis is provided for this market. The report profiles 56 companies including many key and niche players such as Abbott Laboratories, Axcan Pharma, Inc., Digestive Care, Inc., Gilead Sciences, Inc., Eurand N.V., Inspire Pharmaceuticals, Inc., KaloBios Pharmaceuticals, Inc., Nektar Therapeutics, PTC Therapeutics, Inc., Transave, Inc., Vertex Pharmaceuticals, Inc., Actelion Ltd., F. Hoffmann–La Roche Ltd., Novartis AG, and Pharmaxis Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Will the Approval of New Agents Redefine the Cystic Fibrosis Market?
Global Cystic Fibrosis Drug Pipeline Capsule - 2011
Global Cystic Fibrosis Drug Pipeline Capsule - 2012
Biomarker and Diagnostic Opportunities in Respiratory Diseases
Cystic Fibrosis - Pipeline Review, Q4 2010
Cystic Fibrosis (CF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Cystic Fibrosis - Pipeline Review, Q1 2011
Cystic Fibrosis - Pipeline Review, H1 2012
Cystic Fibrosis Global Clinical Trials Review, Q2, 2011
Cystic Fibrosis Global Clinical Trials Review, Q4, 2010
|
|
|
|
